Periodontal Therapy in a Primary Prevention of Cardiovascular Disease
- Conditions
- PeriodontitisCoronary Disease
- Interventions
- Behavioral: Integrated Care GroupOther: Standard Care Group
- Registration Number
- NCT02081976
- Lead Sponsor
- Macmillan Research Group UK
- Brief Summary
Cardiovascular diseases (CVD) are still considered the main cause of mortality and morbidity all over the world. In the last years, efforts have been made to define more effective therapeutic and preventive strategies.Periodontal diseases have been considered a probable risk factor for CVD with a great amount of evidence from observational studies. Although there are some interventional studies evaluating the systemic effects of periodontal therapy, there is little information regarding the impact of periodontal treatment on the prevention of cardiovascular events. To the best of our knowledge, there are no randomized controlled trials published to date assessing the effect of periodontal therapy in primary prevention of CVD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 57
- Individuals having at least 50% of their dentition with periodontal probing pocket depths N4 mm and
- With documented radiographic alveolar bone loss were included
- Known systemic diseases
- History and/or presence of other infections
- Systemic antibiotic treatment in the preceding 3 months
- Treatment with any medication known to affect the serum level of inflammatory markers, lipids, or BP
- Pregnant or lactating females
- Allergy to tetracyclines
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Integrated Care Group Integrated Care Group a combined treatment approach of Dental Therapist, Dental Hygienist, Cardiologist along with counselor Standard Care Group Standard Care Group Dental therapist providing standard periodontal treatment
- Primary Outcome Measures
Name Time Method Traditional cardiovascular risk markers (total cholesterol, LDL-C, HDL-C and triglycerides) Change from baseline to six month
- Secondary Outcome Measures
Name Time Method High- and low-density lipoprotein cholesterol Change from baseline to six month cardiovascular risk scores (Framingham) Change from baseline to six months
Trial Locations
- Locations (1)
GyanSanjeevani
🇮🇳Jaipur, Rajasthan, India